Pasman, Joëlle A. https://orcid.org/0000-0001-7558-0482
Bergstedt, Jacob https://orcid.org/0000-0002-9279-6936
Harder, Arvid
Gong, Tong
Xiong, Ying https://orcid.org/0000-0001-7644-014X
Hägg, Sara
Fang, Fang https://orcid.org/0000-0002-3310-6456
Treur, Jorien L.
Choi, Karmel W. https://orcid.org/0000-0002-3914-2431
Sullivan, Patrick F.
Lu, Yi
Article History
Received: 12 June 2024
Accepted: 4 July 2025
First Online: 22 August 2025
Competing interests
: P.F.S. is consultant and shareholder at Neumora Therapeutics. The other authors declare no competing interests.